The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chair.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Joerg Reinhardt, Ph.D., Board Chair
Joerg Reinhardt, Ph.D.
Chair since 2013
Simon Moroney, Board vice-chair
Simon Moroney, D.Phil.
Board member since 2020 | Vice-Chair since 2022
Nancy C. Andrews, M.D., Ph.D., Board member
Nancy C. Andrews, M.D., Ph.D.
Board member since 2015
Ton Buechner, Board member
Ton Buechner
Board member since 2016
Patrice Bula, Board member
Patrice Bula
Board member since 2019 | Lead Independent Director since 2022
Elizabeth (Liz) Doherty, Board member
Elizabeth (Liz) Doherty
Board member since 2016
Bridgette Heller, Board member
Bridgette Heller
Board member since 2020
Daniel Hochstrasser, Board member
Daniel Hochstrasser
Board member since March 2022
Frans van Houten, Board member
Frans van Houten
Board member since 2017
Ana de Pro Gonzalo, Board member
Ana de Pro Gonzalo
Board member since 2022
Charles L. Sawyers, M.D., Board member
Charles L. Sawyers, M.D.
Board member since 2013
William T. Winters, Board member
William T. Winters
Board member since 2013
John D. Young, Board member
John D. Young
Board member since March 2023
Charlotte Pamer-Wieser, Ph.D., Corporate Secretary
Charlotte Pamer-Wieser, Ph.D.
Corporate Secretary since 2011